Averna Therapeutics

Averna Therapeutics is a genetic-medicine biotechnology company creating what it calls the last, great missing tool required to break through the most persistent barriers in genetic medicine. Backed by Insight Partners, the company was recognized as an Endpoints 11 Most Promising Biotech Company in 2025 and has presented at the 44th Annual J.P. Morgan Healthcare Conference. As a therapeutics R&D company it does not currently publish any public developer program, API, SDK, or API documentation surface; this API Evangelist profile tracks it as a company identity record only.

Averna Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotech Therapeutics, Genetic Medicine, Biotechnology, and Life Sciences.

Averna Therapeutics’ developer surface includes engineering blog and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub

12.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotech TherapeuticsGenetic MedicineBiotechnologyLife SciencesDrug Development

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 12.3/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.4 / 20

Commercial Clarity 4.2 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/averna-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Company 3

The organization behind the API

Website

Website

Blog

Blog

X-LinkedIn

X-LinkedIn

Source (apis.yml)

aid: averna-therapeutics
name: Averna Therapeutics
description: Averna Therapeutics is a genetic-medicine biotechnology company creating what it calls the last, great missing
  tool required to break through the most persistent barriers in genetic medicine. Backed by Insight Partners, the company
  was recognized as an Endpoints 11 Most Promising Biotech Company in 2025 and has presented at the 44th Annual J.P. Morgan
  Healthcare Conference. As a therapeutics R&D company it does not currently publish any public developer program, API, SDK,
  or API documentation surface; this API Evangelist profile tracks it as a company identity record only.
url: https://raw.githubusercontent.com/api-evangelist/averna-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- insight-partners
x-tier: stub
x-tier-reason: portfolio-lead
x-website: https://avernatx.com/
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
image: https://avernatx.com/wp-content/uploads/img-AboutUs.png
tags:
- Company
- Biotech Therapeutics
- Genetic Medicine
- Biotechnology
- Life Sciences
- Drug Development
apis: []
common:
- type: Website
  url: https://avernatx.com/
- type: Blog
  url: https://avernatx.com/#news
- type: PrivacyPolicy
  url: https://avernatx.com/privacy-policy/
- type: TermsOfService
  url: https://avernatx.com/terms-of-use/
- type: X-LinkedIn
  url: https://www.linkedin.com/company/avernatx
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence